Advertisement

Topics

Companies Related to "Clinical grade human umbilical cord derived mesenchymal stem" [Most Relevant Company Matches] RSS

19:07 EST 22nd November 2017 | BioPortfolio

Here are the most relevant search results for "Clinical grade human umbilical cord derived mesenchymal stem" found in our extensive corporate database of over 50,000 company records.

Showing "Clinical grade human umbilical cord derived mesenchymal stem" Companies 1–25 of 6,800+

Extremely Relevant

ViaCell

ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby’s umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases. ViaCell also conducts re...


AmStem Corporation

AmStem Inc. is a corporation registered in the State of Nevada with offices in San Francisco, California and Seoul, Korea. The company is a world leader in the area of stem cell research using stem cells derived from the umbilical cord immediately after birth. The company has 19 U.S. and international patents related to stem cell processing, application an...

LifeSource Cryobank

LifeSource Cryobank is a Louisiana-owned and operated by health care professionals with a concerned interest in future stem cell regenerative and repair therapies. The company stores multiplied adult Mesenchymal stem cells and umbilical cord blood. LifeSource is located at 101 E. Fairway Drive, Suite 502, Covington, LA 70433. (985) 867-8902. www.lifesourcecryoban...


StemCyte, Inc.

StemCyte, Inc. is a leading, global umbilical cord blood ("UCB") stem cell transplantation and therapeutic products company. StemCyte, headquartered in Southern California has UCB storage facilities in both California and in Taiwan which collect, processes and stores UCB stem cells to be used as therapeutic treatments. Stem cells are used to replace or initiate the production of other cells that a...

AuxoCell Laboratories, Inc.

AuxoCell Laboratories, Inc. (AuxoCell) is a leading stem cell therapeutic and regenerative medicine company located in Massachusetts. AuxoCell's primary research focus is to develop the enormous therapeutic potential of the primitive stem cells found in the Wharton's Jelly of the human umbilical cord. With exclusive patent rights and proprietary processing...

Cord Blood Registry

Cord Blood Registry® (CBR®) is the world's largest and most experienced stem cell bank. The company's primary focus is enabling parents to preserve the unique population of stem cells from their newborn's umbilical cord and to ensure the viability of the cells for medical use if needed by the child or immediate family member. During the last two decades, CBR has processed and stored cord bloo...

Insception Biosciences Inc

Insception Biosciences Inc. is a Canadian company founded by Canadian scientists and physicians. We are the country's largest and most established cord blood bank. In 1996, we began as the Toronto Cord Blood Programme and operated out of Toronto General Hospital, and later Toronto's Mount Sinai Hospital.Dr. Robert Casper, Dr. Ian Rogers, and Dr. Barbara Cruickshank, all integral members of The To...

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing numbe...

Shenzhen Beike Biotechnology Company, Ltd.

Shenzhen Beike Biotechnology Co., Ltd. is China's leading biotechnology company focusing on the production of adult stem cells for use in medical therapies. Headquartered in Shenzhen (near Hong Kong) with a flagship regenerative medicine facility at the China Medical City in Jiangsu province, Beike produces a full line of stem cell products derived from umbilical cord, cord blood and autologou...

Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com) is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell ther...

Americord Registry LLC

Americord Registry LLC is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008,...

Americord Registry

Americord Registry is the first cord blood bank to offer Cord Plus, or cryogenic placenta stem cell preservation. Americord focuses on the collection, processing, and storage of newborn stem cells from umbilical cord blood and the placenta for future medical or therapeutic use. Americord is registered with the FDA and the company's laboratory is accredited by the AABB. The company was founded in 2...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell th...

Beike Biotech Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for u...

Shenzhen Beike Biotechnology Co. Ltd.

Beike Biotechnology ( http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for ...

Shenzhen Beike Biotechnology Co., Ltd.

Shenzhen Beike Biotechnology Co., Ltd. ("Beike") is China's leading biotechnology company whose scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of adult stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell therapies are administered by physician...

Cord Blood America

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about this life saving opportunity. We will provide constant care and support to the families whose stem cells we preserve,...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem cell Research Institute in Korea. R-Japan’s proprietary technology is to isolate, multiply, and store adult mesenchymal stem cells with ensuring genetic integrity. R-Japan currently ...

California Stem Cell, Inc.

California Stem Cell, Inc. is a privately held company focused on the manufacture of high-purity human cells for therapeutic development and screening applications. Since its founding in 2005, CSC has developed and has intellectual property surrounding methods for scalable production of human motor neurons, neuronal progenitors, cardiac cells and liver cel...

GeneCell International

GeneCell International, LLC is a trusted provider of collection, processing and storage of umbilical cord blood from which stem cells can be extracted to treat a variety of diseases and disorders. Headquartered in Miami, Florida and with local offices in Central Florida, Texas, Connecticut, Massachusetts, Rhode Island, the Dominican Republic, Panama, and V...

China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Bl...

Relevant

Stemedica Cell Technologies Inc.

Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class, allogeneic, adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government-licensed manufacturer of clini...

Viacord

Being the leader in the cord blood banking and research and development industry means providing the highest quality service, care and science. Since 1993 our dedication to care, and attention to every detail, has made ViaCord a leader in cord blood preservation. Along with our parent company ViaCell we continue to set the standards of cord blood preservation and to research new, life-saving appli...

Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop stem cell modulators, small molecule or biologic compounds that guide cell fate for therapeutic purposes. The Company's award-winning, proprietary iPSC technology platform incorporates the most advanced viral, small molecule and protein reprogramming methods and offer...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases includi...


More From BioPortfolio on "Clinical grade human umbilical cord derived mesenchymal stem"

Quick Search
Advertisement
 

Corporate Database Quicklinks